Divi’s Laboratories
Logotype for Divi’s Laboratories Limited

Divi’s Laboratories (DIVISLAB) investor relations material

Divi’s Laboratories Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Divi’s Laboratories Limited
Q3 25/26 earnings summary11 Feb, 2026

Executive summary

  • Maintained stable operational performance in Q3 FY26, with strong supply reliability and process efficiencies across generics and custom synthesis segments.

  • Healthy volume growth in select emerging products despite competitive pricing pressures in generics.

  • Advanced multiple custom synthesis projects, with several nearing commercial volumes in the next year.

  • Expanded peptide chemistry capabilities, supporting customer programs across all clinical phases.

  • Consolidated total income for Q3 FY26 was ₹2,692 crores, up from ₹2,401 crores in Q3 FY25; nine-month total income reached ₹8,081 crores, up from ₹7,041 crores year-over-year.

Financial highlights

  • Q3 FY26 consolidated total income: INR 2,692 crores (up from INR 2,401 crores YoY); nine-month total income: INR 8,081 crores (vs. INR 7,041 crores YoY).

  • Profit before exceptional item and tax: INR 854 crores (vs. INR 726 crores YoY); after exceptional item, profit before tax: INR 780 crores.

  • Profit after tax: INR 583 crores, broadly in line with INR 589 crores YoY; nine-month PAT was INR 1,817 crores, up from INR 1,529 crores.

  • Material consumption reduced to 36.3% of sales revenue (from 39.8% YoY).

  • Forex gains for Q3 FY26 were INR 19 crores consolidated and INR 18 crores standalone.

Outlook and guidance

  • Operating environment for next six months expected to remain stable in raw material pricing and availability.

  • Double-digit growth trajectory expected to continue, with no major disruptions anticipated from product lifecycle changes.

  • Commercialization of three dedicated custom synthesis projects expected in Q3-Q4 of calendar year 2027, subject to regulatory approvals.

  • Management continues to monitor the finalization of new labour codes and will adjust for any further impacts as regulations are clarified.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Divi’s Laboratories earnings date

Logotype for Divi’s Laboratories Limited
Q4 25/2622 May, 2026
Divi’s Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Divi’s Laboratories earnings date

Logotype for Divi’s Laboratories Limited
Q4 25/2622 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients for global pharmaceutical companies. The company specializes in custom synthesis and contract manufacturing for generic and branded drugs. Divi’s Laboratories serves customers in regulated markets including the United States and Europe. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage